Financing - October 2, 2024
Spago Nanomedical enters a new phase
The Board of Directors of Spago Nanomedical has decided that the company's resources will be focused on the development of Tumorad with the company's primary priority being the execution of the ongoing clinical study Tumorad-01 with the candidate drug 177Lu-SN201.
Financing - October 2, 2024
Senzime carries out a directed share issue of SEK 86 million
The board of directors of Senzime has resolved on a directed share issue of a maximum of 13 873 000 shares at the subscription price of SEK 6.20 per share.
MedTech Award - September 24, 2024
OnDosis wins UX Design Awards in the product category
OnDosis, Tiefenbacher Group and Star's digital product Oysta Digital Service has been awarded the UX Design Awards Design Award in the Product category.
Agreement - July 1, 2024
SciBase partner with a large health care group in Los Angeles
SciBase Holding continues to expand in California with a collaboration agreement with Unified Health. Unified Health has nine clinics in Southern California. “At Unified Health, we believe in providing our patients with exceptional medical care and access to the most advance medical technology. Our experienced team of providers are committed to delivering the highest quality […]
Financing - June 19, 2024
Medfield Diagnostics files for bankruptcy
The Board of Directors of Medfield Diagnostics has decided to apply to declare the company bankrupt. The bankruptcy application was filed June 18, 2024, with the Gothenburg District Court and it has approved the file for bankruptcy of Medfield Diagnostics. The reason for the bankruptcy filing is that, despite intensive work in 2024, Medfield has not […]
Biotech Business - May 15, 2024
ArgusEye secures EUR 2.8 million
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.